EDNRA and systemic sclerosis: The capacity to restore endothelial function in SSc pharmacologically has been reported with dihydropyridine calcium channel blockers, statins, nitrate, endothelin-1 receptor antagonists, phosphodiesterase-5 inhibitors, soluble guanylate cyclase activators, prostacyclins, and cyclophosphamide (8),.